SCHEMBL675123

SCHEMBL675123

CCC(O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3475260 1.00
SCHEMBL16486381 1.00
SCHEMBL9286503 0.77
SCHEMBL4040311 0.75
SCHEMBL737214 0.72 TSHR (0.44)
SCHEMBL56356 0.72
SCHEMBL2575567 0.71
SCHEMBL10403578 0.69
SCHEMBL10402451 0.69
SCHEMBL6738125 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150285-A1 MODULATORS OF COMPLEX I BOEHRINGER INGELHEIM INT (DE) 2024-05-09 US claimed
EP-4291552-A1 MODULATORS OF COMPLEX I Boehringer Ingelheim International GmbH (DE) 2023-12-20 EP claimed
CN-117120476-A Antibodies specific for structurally disordered sequences XL-普洛坦公司 2023-11-24 CN claimed
EP-4267628-A1 ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES XL-protein GmbH (DE) 2023-11-01 EP claimed
US-11795147-B2 Modulators of complex I BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-10-24 US claimed
CN-116848101-A Modulators of complex I 勃林格殷格翰国际有限公司 2023-10-03 CN claimed
US-11767521-B2 Genetically modified bacterial cells and methods useful for producing indigoidine THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-09-26 US claimed
WO-2022136582-A1 ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES XL-PROTEIN GMBH (DE) 2022-06-30 WO claimed
US-20220204473-A1 COMPOUND AS IRAK INHIBITOR WUHAN CREATERNA SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2022-06-30 US claimed
CN-108137547-B Heterocyclic compounds useful as TNF alpha modulators 百时美施贵宝公司 2021-11-12 CN claimed
US-4663352-A Use of some alkanoyl L-carnitines for the therapeutical treatment of idiopathic and induced Parkinsonism SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1987-05-05 US claimed
EP-0207011-A2 Use of some alkanoyl L-carnitines for the manufacture of a medicament for therapeutical treatment of idiopathic and induced Parkinsonism Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1986-12-30 EP claimed
US-4464393-A Use of alkanoyl L-carnitines in the therapeutical treatment of myopathies and muscular dystrophies SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1984-08-07 US claimed
US-4362719-A INSULIN, MIXTURES CAVAZZA CLAUDIO 1982-12-07 US claimed
US-4346107-A SENILITY Cavazza, Claudio (IT) 1982-08-24 US claimed
US-4343816-A Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases CAVAZZA CLAUDIO 1982-08-10 US claimed
EP-0048614-A1 1-N-acylated and 1-N-alkylated derivatives of 4-0-substituted -2-deoxystreptamine aminoglycosides ELI LILLY AND COMPANY (US) 1982-03-31 EP claimed
US-4320145-A Pharmaceutical composition for parenteral nutrition comprising L-carnitine or acyl L-carnitines SIGMA-TAU INC. 1982-03-16 US claimed
US-4268524-A Method of treating abnormal lipoprotein ratios with acylcarnitine CAVAZZA CLAUDIO 1981-05-19 US claimed
US-4194006-A ANTIARRHYTHMIA CAVAZZA CLAUDIO (IT) 1980-03-18 US claimed